Tracking vaginal microbiome transitions in bacterial vaginosis for cues of antibiotic resilience
Apoorva ChallaiD, Afrin Zulfia S, Anwesha MohapatraiD, Sunil NagpaliD, Mohammed Monzoorul HaqueiD, Seema SoodiD, Garima KachhawaiD, Geetha ThiagarajaniD, Bhupesh TanejaiD, Somesh Gupta
Abstract
BackgroundBacterial vaginosis (BV) is a common and difficult-to-treat vaginal disorder, with significant implications for reproductive health, particularly in low and middle-income countries. Clinical cure based on symptom resolution or Nugent scores often do not correspond to restoration of healthy vaginal microbiome. Factors underlying treatment failure remain poorly defined, warranting the need for understanding post-treatment microbiome dynamics to improve long-term outcomes. ObjectivesTo delineate longitudinal vaginal bacteriome dynamics, integrating microbial composition, transition patterns, and clinical symptoms in a closely followed cohort of women with BV based on treatment outcome. MethodsVaginal swabs from reproductive-age women (18-45 years) were collected and classified as BV-positive ([≥]7) or healthy ([≤]3) using Nugent scoring. BV cases were treated using single-dose secnidazole and followed for three months. Sociodemographic, clinical, and behavioral data were statistically analyzed across groups. Vaginal microbiome composition was assessed using 16S rRNA sequencing, evaluating taxonomic profiles, alpha and beta diversity, differential abundance, and co-occurrence networks. ResultsAntibiotic treatment reduced overall microbial diversity and shifted community composition toward healthy controls, though relapse samples retained higher diversity of BV-associated taxa such as Sneathia, Dialister, and Gardnerella, while no-relapse and control groups showed higher Lactobacillus abundance. Corynebacterium amycolatum appeared protective, while Mycoplasma and Fusobacterium played symptom-specific roles. Microbial network analysis showed denser and more persistent associations in baseline and relapse groups, with Sneathia remaining a central node. ConclusionShort-term symptom resolution in BV does not correspond to full microbial recovery; necessary for long-term remission. Functional traits of resilient taxa like Sneathia, Fannyhessea and Dialister may confer resilience and enable recolonization, undermining long term treatment efficacy.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Temporal Dynamics of the Vaginal Microbiome and Host Immune Markers Before, During, and After Metronidazole Treatment for Bacterial Vaginosis
Amanda L. Williams, Jacques Ravel, … Johanna B. Holm·mSystemsPeer-reviewed·Jul 3, 2025
- Exposure to Antibiotics Modifies the Immune Profiles of Bacterial Extracellular Vesicles from Common Vaginal Anaerobes
Yu Hasegawa, Olivia Swain, … Michal A. Elovitz·MicrobiomePeer-reviewed·Sep 10, 2026
- Vaginal metatranscriptome meta-analysis reveals functional BV subgroups and novel colonisation strategies
Scott J Dos Santos, Clara Copeland, … Gregory Brian Gloor·MicrobiomePeer-reviewed·Dec 21, 2024
- Metatranscriptome analysis of the vaginal microbiota reveals potential mechanisms for protection against metronidazole in bacterial vaginosis
Z.-L. Deng, C. Gottschick, … I. Wagner-Doebler·bioRxiv·May 11, 2018
- Characterization of vaginal microbiomes in clinician-collected bacterial vaginosis diagnosed samples
Hayden N. Brochu, Qimin Zhang, … Lakshmanan K. Iyer·Microbiology SpectrumPeer-reviewed·Feb 25, 2025
- Identifying a Vaginal Microbiome-Derived Selective Antibiotic Metabolite via Microbiome Pharmacology Analysis
Smrutiti Jena, Damilola C. Lawore, … Douglas K. Brubaker·bioRxiv·Aug 28, 2025